Improving Patient Care With Advanced Sterile Processing In 2025 And Beyond

Executive Summary

As healthcare continues to evolve, companies are developing new methods to ensure the highest level of sterilization for medical instruments. Advancements in technology are expanding what's possible, allowing for more efficient, reliable, and innovative solutions to meet the growing demands of sterile processing departments (SPDs). This report discusses product trends, company strategies, statements from key opinion leaders (KOLs), and insights from analysts. 

Introduction

The fundamental principle remains constant: thoroughly cleaned, disinfected, and sterilized medical instruments are paramount to preventing infections and ensuring optimal patient outcomes. However, the complexity of modern healthcare, with its increasingly sophisticated surgical procedures and instruments, escalating surgical volumes, and persistent threats of antimicrobial resistance, has propelled sterile processing into a new era of innovation and strategic importance. This report aims to provide a comprehensive overview of the current and emerging trends that are transforming sterile processing, underscoring its pivotal role in enhancing patient safety and satisfaction.

Below Table Represents National standardized infection ratios (SIRs) and facility-specific summary SIRs using adult surgical site infection (SSI) data1 reported to NHSN from NHSN Acute Care

Source: CDC

Below Graph represent: State-specific standardized infection ratios (SIRs) and facility-specific SIR summary measures: NHSN Acute Care Hospitals reporting during 2023, Central line-associated bloodstream infections (CLABSI), all locations

Below Graphs represent: State-specific standardized infection ratios (SIRs) and facility-specific SIR summary measures, NHSN Acute Care Hospitals reporting during 2023, Surgical site infections (SSI) following hip arthroplasty1 in adults, ≥ 18years:

Key Trends and Impact

Technological Advancements in Sterilization and Instrument Reprocessing:

The instruments themselves are becoming more complex, demanding sophisticated reprocessing techniques. This has spurred innovation in sterilization technology.

• Adoption of HLD: The focus is on high-level disinfection (HLD) and advancements in sterilization technologies for intricate instruments like flexible endoscopes and robotic surgical tools. Innovations include UV-C radiation systems for rapid disinfection without chemicals, and vaporized hydrogen peroxide technology for heat-sensitive and 3D-printed devices. These technologies ensure a higher degree of sterility, reducing the risk of pathogen transmission, especially for devices with complex lumens or materials. Enhanced electronic traceability within these systems provides auditable records, further bolstering safety and compliance.

• Growing focus on automation of reprocessing: Industry players are launching automated medical device reprocessing solutions to capitalize on the growing demand.. For instance, CS Medical launched its Ethos Automated Ultrasound Probe Cleaner Disinfector, a Class II medical device approved by the U.S. FDA in June 2023. Ethos is the first device in North America to offer both high-level disinfection and cleaning for surface and endocavity ultrasound probes. It reduces the time and labor involved in reprocessing by eliminating manual steps and creating repeatable & validated processes for medical device reprocessing.

Companies are also launching products to protect patients and ensure sterility across modalities. For instance, in October 2023, ASP reported a substantial expansion in its sterilization monitoring portfolio with new steam monitoring products to help SPDs in healthcare facilities ensure greater sterility, efficiency, and effectiveness.

The new solutions support compliance across all major sterilization modalities and include:

• BIOTRACE Readers - Enable faster result reading and better workflow integration.

• BIOTRACE Biological Indicators - Offer streamlined, traceable monitoring for steam sterilization.

• VERISURE Chemical Indicators - Allow quick, easy sterilization process checks.

• SEALSURE Steam Indicator Tape - Visually distinguishes processed from unprocessed items.

“With a strong history of excellence in Sterile Processing, ASP is extending its expertise into steam sterilization monitoring. This enhanced sterilization monitoring portfolio is aimed at supporting our customers in SPD/CSSD and will allow hospitals to reprocess instruments across all major modalities with greater speed, compliance, and confidence,” said Chad Rohrer, President of ASP. “With this enhanced portfolio, ASP further demonstrates its commitment to advancing sterility assurance and continues its mission to protect patients during their most critical moments.”

Rise of VH₂O₂ Technology in Low-Temperature Sterilization

Healthcare facilities are increasingly adopting Vaporized Hydrogen Peroxide (VH₂O₂) sterilization to process delicate, heat-sensitive instruments safely. This low-temperature, residue-free method ensures effective microbial inactivation while preserving device integrity. The trend reflects growing demand for safer, efficient sterilization and improved infection control in Sterile Processing Departments. Companies are launching VH₂O₂ Technology based products.

For example: in June 2024, Getinge introduced the Poladus 150, an advanced VH₂O₂ low-temperature sterilizer designed for modern surgical needs.

Product & Technology Highlights:

• VH₂O₂ Sterilization Technology: Delivers efficient, low-residue sterilization suitable for sensitive instruments.

• Operates at Up to 55°C: Ideal for sterilizing heat- and moisture-sensitive devices.

• Supports Multiple Instrument Types: Compatible with non-lumen, flexible lumen, and rigid lumen instruments.

• Cross-Contamination Barrier Technology: Enhances patient safety by minimizing the risk of healthcare-associated infections (HCAIs).

"Today marks a significant milestone for our Infection Control business. The Poladus 150 materializes our ambition to be a leading player in the field of VH2O2 low-temperature sterilization, which is one of the most dynamic segments, with the development of more and more advanced endoscopic and robotic procedures. This product launch is a great addition to our portfolio for central sterile supply departments (CSSDs)," says Stéphane Le Roy, President of Surgical Workflows at Getinge.

“It offers competitive sterilization claims and capacity, ensuring a safe and effective way of reprocessing both flexible and rigid instruments used in endoscopy and surgical operations,” says Sophia Brüggemann, Product Manager at Getinge.

Impact on Patient Safety Due to Technological Advancements

• Reduces healthcare-associated infections (HCAIs) through effective VH₂O₂ sterilization and HLD.

• Enables safe sterilization of heat-sensitive and complex surgical instruments.

• Enhances consistency and reliability in reprocessing with automated systems.

• Minimizes human error, improving sterility assurance.

• Supports compliance with infection control standards and protocols.

Workforce Challenges in Sterile Processing Departments

Despite technological advancements, a critical barrier to effective sterile processing remains the shortage of trained personnel and limited awareness around proper reprocessing practices.

• According to the U.S. Bureau of Labor Statistics, employment for sterile processing technicians is projected to grow by 6% between 2021 and 2031, reflecting increasing demand amid persistent staffing shortages.

These challenges can compromise sterility standards, ultimately affecting patient safety and satisfaction. Addressing this workforce gap is essential to sustain high-quality care and infection prevention in 2025 and beyond.

Some of the key players operating in the sterile processing sector include: